Human secreted phospholipases A2 (sPLA2s) represent novel attractive therapeutic targets and biomarkers in coronary artery diseases (CAD). We have shown that human Group X sPLA2 (hGX sPLA2) is present in atherosclerotic lesions and that hGX sPLA2 modiÀ ed LDL induces foam cell formation. To elucidate whether hGX sPLA2 has a causative role in CAD we have screened the human PLA2G10 gene to identify frequent polymorphisms, and we have examined their possible association with cardiovascular end-points and intermediate inÁ ammatory phenotypes in a large prospective study of patients with CAD (the AtheroGene study). Although no signiÀ cant association was found between the various polymorphisms identiÀ ed and lipids or inÁ ammatory markers, patients carriers of the C allele of the T-512C polymorphism located in the 5' untranslated region showed a decreased risk of recurrent cardiovascular events. Molecular analysis of the only missense variant (R38C) showed its functional relevance as it leads to a profound change in expression and secretion of hGX sPLA2. Objectives -Vascular Cell Adhesion Molecule-1 (VCAM-1) plays a major role in the chronic inÁ ammatory processes involved in vulnerable atherosclerotic plaque development. It has been shown that the technetium-labelled HMC-I derived peptide B2702p bound speciÀ cally to VCAM-1 and allowed the ex vivo imaging of atherosclerotic lesions in WHHL rabbits. However, B2702p targetto-background ratio was suboptimal for in vivo imaging of VCAM-1 expression in atherosclerotic lesions. In order to increase the target to background ratio, ten derivatives of B2702p were synthesized (B2702p-1 to 10). We hypothesized that technetium radiolabelled B2702p derivatives might allow the molecular imaging of VCAM-1 expression in an experimental model of atherosclerosis.
thromboxane A2, as reported in our previous manuscript (Mostefai et al. 2008 ). These data demonstrate that IL-10 restores the vascular hyporeactivity induced by LPS in tissue-engineered blood vessel models. Human secreted phospholipases A2 (sPLA2s) represent novel attractive therapeutic targets and biomarkers in coronary artery diseases (CAD). We have shown that human Group X sPLA2 (hGX sPLA2) is present in atherosclerotic lesions and that hGX sPLA2 modiÀ ed LDL induces foam cell formation. To elucidate whether hGX sPLA2 has a causative role in CAD we have screened the human PLA2G10 gene to identify frequent polymorphisms, and we have examined their possible association with cardiovascular end-points and intermediate inÁ ammatory phenotypes in a large prospective study of patients with CAD (the AtheroGene study). Although no signiÀ cant association was found between the various polymorphisms identiÀ ed and lipids or inÁ ammatory markers, patients carriers of the C allele of the T-512C polymorphism located in the 5' untranslated region showed a decreased risk of recurrent cardiovascular events. Molecular analysis of the only missense variant (R38C) showed its functional relevance as it leads to a profound change in expression and secretion of hGX sPLA2. Objectives -Vascular Cell Adhesion Molecule-1 (VCAM-1) plays a major role in the chronic inÁ ammatory processes involved in vulnerable atherosclerotic plaque development. It has been shown that the technetium-labelled HMC-I derived peptide B2702p bound speciÀ cally to VCAM-1 and allowed the ex vivo imaging of atherosclerotic lesions in WHHL rabbits. However, B2702p targetto-background ratio was suboptimal for in vivo imaging of VCAM-1 expression in atherosclerotic lesions. In order to increase the target to background ratio, ten derivatives of B2702p were synthesized (B2702p-1 to 10). We hypothesized that technetium radiolabelled B2702p derivatives might allow the molecular imaging of VCAM-1 expression in an experimental model of atherosclerosis.
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IDENTIFICATION OF POLYMORPHISMS IN THE GENE ENCODING SECRETED PHOSPHOLIPASE A2 GROUP X AND STUDY OF THEIR ROLE IN CORONARY ARTERY DISEASE. THE ATHEROGENE STUDY
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IN VIVO MOLECULAR IMAGING OF VASCULAR CELL ADHESION MOLECULE-1 EXPRESSION IN ATHEROSCLEROTIC PLAQUES
Material and Methods -A mouse model of focal atherosclerotic plaque development induced by left carotid artery ligation in ApoE-/-mice was used. 99mTc-B2702p (n=9) and 99mTc-B2702p-1 -10 (n=3 for each except B2702p-1, n=5, and B2702p-4, n=5) were injected intravenously to the anesthetized animals 3 weeks following the ligation. Whole-body planar image acquisition was performed for 3 hrs with all radiolabelled peptides and SPECT imaging of 6 additionnal mice was also performed with 99mTc-B2702p-1. The animals were then euthanized and the biodistribution evaluated by gamma-well counting of excised organs. The expression of VCAM-1 in the ligated and contralateral arteries was evaluated by immunohistology.
Results -A robust VCAM-1 immunostaining was observed in ApoE-/-mice in the atherosclerotic lesions at the level of the left carotid whereas no VCAM-1 expression was detected in the contralateral carotid. Among the ten evaluated peptides, 99mTc-B2702p-1 exhibited the more favourable properties. By gamma-well counting, there was a signiÀ cant 2.0-fold increase in 99mTc-B2702p-1 left-toright carotid artery activity ratio (2.61±0.61) and a 3.4-fold increase in left carotid-to-blood activity ratio (1.41±0.36) in comparison to 99mTc-B2702p (1.32±0.23 and 0.41±0.09, respectively, P<0.05 for both comparisons). Finally, a higher 99mTc-B2702p-1 activity in the left than in the right carotid was observed by SPECT imaging (33.3±5.8 vs. 25.1±5.3 cpm/mm²/ID, respectively, P<0.05). The generation of mice overexpressing FcgRIIb on macrophages (M-TG) allowed us to explore the speciÀ c role of macrophages FcgRIIb expression in the development of atherosclerosis. To this end, we reconstitued lethally irradiated LDLr-deÀ cient mice with bone marrow cells of either control or M-TG and after 4weeks of recovery mice have been subjected to high fat diet during 11 weeks to induce atherogenesis. Our results show that LDLr -/-mice reconstitued with bone marrow of M-TG have 21 % reduction of atherosclerotic plaque size in aortic sinus in comparison with control (p=0.01) despite a similar cholesterol level in both groups and the development of very advanced lesions. CD3-stimulated splenic T cells isolated from M-TG mice produced 46 % less IFNg (P<0.01) than CD4+ T cells from control mice but same levels of IL4. There was no difference in the ability of regulatory T cells (Tregs) to inhibit effector CD4+ cells proliferation. However, using Á ow cytometry we found a 34 % increase of Tregs (CD4+, CD25+, Foxp3+) among CD4+ cells in LDLr-/-M-TG mice compared to control mice (p<0.01).
Conclusion
These results clearly show that FcgRIIb overexpression on macrophages reduces atherosclerosis plaque development by triggering a phenotype shift of immune cells involved in atherosclerosis. Additional experiments are ongoing to understand mechanisms that induce T cell modulation. Objectifs -Les télomères sont des structures nucléoprotéiques situées à l'extrémité des chromosomes. Leur fonction est de maintenir l'intégrité du génome au cours des divisions successives de la cellule. Du fait de leur forte proportion en guanine, ces structures sont très sensibles aux atteintes oxydantes et leur implication est démontrée dans les pathologies cardiovasculaires où une composante inÁ ammatoire existe. Les objectifs notre étude ont été de déterminer les liens pouvant exister entre la longueur des télomères et certains paramètres géniques, métaboliques et cliniques chez des patients admis en Unité de Soins Intensifs Cardiologiques pour un infarctus du myocarde. 
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LA LONGUEUR DES TÉLOMÈRES LEUCOCYTAIRES EST ASSOCIÉE À LA VARIATION DE PARAMÈTRES FONCTIONNELS, BIOLOGIQUES ET GÉNIQUES CHEZ DES PATIENTS PRÉSENTANT UN INFARCTUS DU MYOCARDE
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